{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:03:25Z","timestamp":1760015005627},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T00:00:00Z","timestamp":1401408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s11060-014-1490-6","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T16:12:02Z","timestamp":1401379922000},"page":"377-385","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Lower apparent diffusion coefficients indicate distinct prognosis in low-grade and high-grade glioma"],"prefix":"10.1007","volume":"119","author":[{"given":"Yong","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haihui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,30]]},"reference":[{"key":"1490_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","volume":"114","author":"DN Louis","year":"2007","unstructured":"Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97\u2013109. doi: 10.1007\/s00401-007-0243-4","journal-title":"Acta Neuropathol"},{"key":"1490_CR2","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2004.10.169","volume":"22","author":"K Hoang-Xuan","year":"2004","unstructured":"Hoang-Xuan K, Capelle L, Kujas M, Taillibert S, Duffau H, Lejeune J, Polivka M, Criniere E, Marie Y, Mokhtari K, Carpentier AF, Laigle F, Simon JM, Cornu P, Broet P, Sanson M, Delattre JY (2004) Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol 22:3133\u20133138. doi: 10.1200\/JCO.2004.10.169","journal-title":"J Clin Oncol"},{"key":"1490_CR3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1212\/01.wnl.0000262034.26310.a2","volume":"68","author":"G Kaloshi","year":"2007","unstructured":"Kaloshi G, Benouaich-Amiel A, Diakite F, Taillibert S, Lejeune J, Laigle-Donadey F, Renard MA, Iraqi W, Idbaih A, Paris S, Capelle L, Duffau H, Cornu P, Simon JM, Mokhtari K, Polivka M, Omuro A, Carpentier A, Sanson M, Delattre JY, Hoang-Xuan K (2007) Temozolomide for low-grade gliomas: predictive impact of 1p\/19q loss on response and outcome. Neurology 68:1831\u20131836. doi: 10.1212\/01.wnl.0000262034.26310.a2","journal-title":"Neurology"},{"key":"1490_CR4","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1200\/JCO.1994.12.10.2013","volume":"12","author":"G Cairncross","year":"1994","unstructured":"Cairncross G, Macdonald D, Ludwin S, Lee D, Cascino T, Buckner J, Fulton D, Dropcho E, Stewart D, Schold C Jr (1994) Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013\u20132021","journal-title":"J Clin Oncol"},{"key":"1490_CR5","first-page":"839","volume":"7","author":"Y Ino","year":"2001","unstructured":"Ino Y, Betensky RA, Zlatescu MC, Sasaki H, Macdonald DR, Stemmer-Rachamimov AO, Ramsay DA, Cairncross JG, Louis DN (2001) Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. Clin Cancer Res 7:839\u2013845","journal-title":"Clin Cancer Res"},{"key":"1490_CR6","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/neuonc\/5.2.128","volume":"5","author":"M Bent van den","year":"2003","unstructured":"van den Bent M, Chinot OL, Cairncross JG (2003) Recent developments in the molecular characterization and treatment of oligodendroglial tumors. Neuro Oncol 5:128\u2013138. doi: 10.1215\/S1522-8517-02-00028-5","journal-title":"Neuro Oncol"},{"key":"1490_CR7","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1200\/JCO.2009.21.9832","volume":"27","author":"M Sanson","year":"2009","unstructured":"Sanson M, Marie Y, Paris S, Idbaih A, Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K, Hoang-Xuan K, Delattre JY (2009) Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol 27:4150\u20134154. doi: 10.1200\/JCO.2009.21.9832","journal-title":"J Clin Oncol"},{"key":"1490_CR8","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1212\/WNL.0b013e3181f96282","volume":"75","author":"C Houillier","year":"2010","unstructured":"Houillier C, Wang X, Kaloshi G, Mokhtari K, Guillevin R, Laffaire J, Paris S, Boisselier B, Idbaih A, Laigle-Donadey F, Hoang-Xuan K, Sanson M, Delattre JY (2010) IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. Neurology 75:1560\u20131566. doi: 10.1212\/WNL.0b013e3181f96282","journal-title":"Neurology"},{"key":"1490_CR9","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1200\/JCO.2002.08.121","volume":"20","author":"F Pignatti","year":"2002","unstructured":"Pignatti F, van den Bent M, Curran D, Debruyne C, Sylvester R, Therasse P, Afra D, Cornu P, Bolla M, Vecht C, Karim AB (2002) Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:2076\u20132084. doi: 10.1200\/JCO.2002.08.121","journal-title":"J Clin Oncol"},{"key":"1490_CR10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa043330","volume":"352","author":"R Stupp","year":"2005","unstructured":"Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987\u2013996. doi: 10.1056\/NEJMoa043330","journal-title":"N Engl J Med"},{"key":"1490_CR11","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1158\/1078-0432.CCR-03-0384","volume":"10","author":"ME Hegi","year":"2004","unstructured":"Hegi ME, Diserens AC, Godard S, Dietrich PY, Regli L, Ostermann S, Otten P, Van Melle G, de Tribolet N, Stupp R (2004) Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res 10:1871\u20131874. doi: 10.1158\/1078-0432.CCR-03-0384","journal-title":"Clin Cancer Res"},{"key":"1490_CR12","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1073\/pnas.0508347102","volume":"102","author":"DA Hamstra","year":"2005","unstructured":"Hamstra DA, Chenevert TL, Moffat BA, Johnson TD, Meyer CR, Mukherji SK, Quint DJ, Gebarski SS, Fan X, Tsien CI, Lawrence TS, Junck L, Rehemtulla A, Ross BD (2005) Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci USA 102:16759\u201316764. doi: 10.1073\/pnas.0508347102","journal-title":"Proc Natl Acad Sci USA"},{"key":"1490_CR13","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1200\/JCO.2007.15.2363","volume":"26","author":"DA Hamstra","year":"2008","unstructured":"Hamstra DA, Galban CJ, Meyer CR, Johnson TD, Sundgren PC, Tsien C, Lawrence TS, Junck L, Ross DJ, Rehemtulla A, Ross BD, Chenevert TL (2008) Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol 26:3387\u20133394. doi: 10.1200\/JCO.2007.15.2363","journal-title":"J Clin Oncol"},{"key":"1490_CR14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jon199553157","volume":"5","author":"L Chang","year":"1995","unstructured":"Chang L, McBride D, Miller BL, Cornford M, Booth RA, Buchthal SD, Ernst TM, Jenden D (1995) Localized in vivo 1H magnetic resonance spectroscopy and in vitro analyses of heterogeneous brain tumors. J Neuroimaging 5:157\u2013163","journal-title":"J Neuroimaging"},{"key":"1490_CR15","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/jnci\/92.24.2029","volume":"92","author":"TL Chenevert","year":"2000","unstructured":"Chenevert TL, Stegman LD, Taylor JM, Robertson PL, Greenberg HS, Rehemtulla A, Ross BD (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 92:2029\u20132036. doi: 10.1093\/jnci\/92.24.2029","journal-title":"J Natl Cancer Inst"},{"key":"1490_CR16","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2","volume":"9","author":"T Sugahara","year":"1999","unstructured":"Sugahara T, Korogi Y, Kochi M, Ikushima I, Shigematu Y, Hirai T, Okuda T, Liang L, Ge Y, Komohara Y, Ushio Y, Takahashi M (1999) Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas. J Magn Reson Imaging 9:53\u201360. doi: 10.1002\/(SICI)1522-2586(199901)9:1<53:AID-JMRI7>3.0.CO;2-2","journal-title":"J Magn Reson Imaging"},{"key":"1490_CR17","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1093\/neuonc\/nor122","volume":"13","author":"IS Khayal","year":"2011","unstructured":"Khayal IS, Vandenberg SR, Smith KJ, Cloyd CP, Chang SM, Cha S, Nelson SJ, McKnight TR (2011) MRI apparent diffusion coefficient reflects histopathologic subtype, axonal disruption, and tumor fraction in diffuse-type grade II gliomas. Neuro Oncol 13:1192\u20131201. doi: 10.1093\/neuonc\/nor122","journal-title":"Neuro Oncol"},{"key":"1490_CR18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1006431120031","volume":"50","author":"RK Gupta","year":"2000","unstructured":"Gupta RK, Cloughesy TF, Sinha U, Garakian J, Lazareff J, Rubino G, Rubino L, Becker DP, Vinters HV, Alger JR (2000) Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J Neurooncol 50:215\u2013226. doi: 10.1023\/A:1006431120031","journal-title":"J Neurooncol"},{"key":"1490_CR19","first-page":"1081","volume":"22","author":"K Kono","year":"2001","unstructured":"Kono K, Inoue Y, Nakayama K, Shakudo M, Morino M, Ohata K, Wakasa K, Yamada R (2001) The role of diffusion-weighted imaging in patients with brain tumors. Am J Neuroradiol 22:1081\u20131088","journal-title":"Am J Neuroradiol"},{"key":"1490_CR20","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1148\/radiol.2413051276","volume":"241","author":"S Higano","year":"2006","unstructured":"Higano S, Yun X, Kumabe T, Watanabe M, Mugikura S, Umetsu A, Sato A, Yamada T, Takahashi S (2006) Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. Radiology 241:839\u2013846. doi: 10.1148\/radiol.2413051276","journal-title":"Radiology"},{"key":"1490_CR21","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1148\/radiol.2432060450","volume":"243","author":"R Murakami","year":"2007","unstructured":"Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y (2007) Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology 243:493\u2013499. doi: 10.1148\/radiol.2432060450","journal-title":"Radiology"},{"key":"1490_CR22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.ejrad.2009.01.013","volume":"73","author":"F Yamasaki","year":"2010","unstructured":"Yamasaki F, Sugiyama K, Ohtaki M, Takeshima Y, Abe N, Akiyama Y, Takaba J, Amatya VJ, Saito T, Kajiwara Y, Hanaya R, Kurisu K (2010) Glioblastoma treated with postoperative radio-chemotherapy: prognostic value of apparent diffusion coefficient at MR imaging. Eur J Radiol 73:532\u2013537. doi: 10.1016\/j.ejrad.2009.01.013","journal-title":"Eur J Radiol"},{"key":"1490_CR23","doi-asserted-by":"crossref","first-page":"624","DOI":"10.2214\/AJR.12.8679","volume":"200","author":"M Zulfiqar","year":"2013","unstructured":"Zulfiqar M, Yousem DM, Lai H (2013) ADC values and prognosis of malignant astrocytomas: does lower ADC predict a worse prognosis independent of grade of tumor?\u2013a meta-analysis. Am J Roentgenol 200:624\u2013629. doi: 10.2214\/AJR.12.8679","journal-title":"Am J Roentgenol"},{"key":"1490_CR24","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1148\/radiol.2532081623","volume":"253","author":"G Brasil Caseiras","year":"2009","unstructured":"Brasil Caseiras G, Ciccarelli O, Altmann DR, Benton CE, Tozer DJ, Tofts PS, Yousry TA, Rees J, Waldman AD, Jager HR (2009) Low-grade gliomas: six-month tumor growth predicts patient outcome better than admission tumor volume, relative cerebral blood volume, and apparent diffusion coefficient. Radiology 253:505\u2013512. doi: 10.1148\/radiol.2532081623","journal-title":"Radiology"},{"key":"1490_CR25","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.6004\/jnccn.2013.0133","volume":"11","author":"National Comprehensive Cancer Network","year":"2013","unstructured":"National Comprehensive Cancer Network (2013) NCCN Guidelines\u00ae updates. J Natl Compr Canc Netw 11:1153\u20131164","journal-title":"J Natl Compr Canc Netw"},{"key":"1490_CR26","doi-asserted-by":"crossref","first-page":"e32764","DOI":"10.1371\/journal.pone.0032764","volume":"7","author":"X Ren","year":"2012","unstructured":"Ren X, Cui X, Lin S, Wang J, Jiang Z, Sui D, Li J, Wang Z (2012) Co-deletion of chromosome 1p\/19q and IDH1\/2 mutation in glioma subsets of brain tumors in Chinese patients. PLoS One 7:e32764. doi: 10.1371\/journal.pone.0032764","journal-title":"PLoS One"},{"key":"1490_CR27","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/mpo.1242","volume":"37","author":"PF Ambros","year":"2001","unstructured":"Ambros PF, Ambros IM (2001) Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines. Med Pediatr Oncol 37:492\u2013504. doi: 10.1002\/mpo.1242","journal-title":"Med Pediatr Oncol"},{"key":"1490_CR28","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11060-012-1026-x","volume":"111","author":"H Jiang","year":"2013","unstructured":"Jiang H, Ren X, Zhang W, Ma J, Sui D, Jiang Z, Cui X, Lin S (2013) A new prognostic scoring scale for patients with primary WHO grade III gliomas based on molecular predictors. J Neurooncol 111:367\u2013375. doi: 10.1007\/s11060-012-1026-x","journal-title":"J Neurooncol"},{"key":"1490_CR29","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2010.05.003","volume":"81","author":"TB Daniels","year":"2011","unstructured":"Daniels TB, Brown PD, Felten SJ, Wu W, Buckner JC, Arusell RM, Curran WJ, Abrams RA, Schiff D, Shaw EG (2011) Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218\u2013224. doi: 10.1016\/j.ijrobp.2010.05.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1490_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11060-008-9719-x","volume":"91","author":"FW Crawford","year":"2009","unstructured":"Crawford FW, Khayal IS, McGue C, Saraswathy S, Pirzkall A, Cha S, Lamborn KR, Chang SM, Berger MS, Nelson SJ (2009) Relationship of pre-surgery metabolic and physiological MR imaging parameters to survival for patients with untreated GBM. J Neurooncol 91:337\u2013351. doi: 10.1007\/s11060-008-9719-x","journal-title":"J Neurooncol"},{"key":"1490_CR31","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/jmri.22068","volume":"31","author":"BM Ellingson","year":"2010","unstructured":"Ellingson BM, Malkin MG, Rand SD, Connelly JM, Quinsey C, LaViolette PS, Bedekar DP, Schmainda KM (2010) Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity. J Magn Reson Imaging 31:538\u2013548. doi: 10.1002\/jmri.22068","journal-title":"J Magn Reson Imaging"},{"key":"1490_CR32","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3174\/ajnr.A3352","volume":"34","author":"S Fellah","year":"2013","unstructured":"Fellah S, Caudal D, De Paula AM, Dory-Lautrec P, Figarella-Branger D, Chinot O, Metellus P, Cozzone PJ, Confort-Gouny S, Ghattas B, Callot V, Girard N (2013) Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p\/19q codeletion in the pretherapeutic diagnosis? Am J Neuroradiol 34:1326\u20131333. doi: 10.3174\/ajnr.A3352","journal-title":"Am J Neuroradiol"},{"key":"1490_CR33","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11060-012-0847-y","volume":"108","author":"WB Pope","year":"2012","unstructured":"Pope WB, Qiao XJ, Kim HJ, Lai A, Nghiemphu P, Xue X, Ellingson BM, Schiff D, Aregawi D, Cha S, Puduvalli VK, Wu J, Yung WK, Young GS, Vredenburgh J, Barboriak D, Abrey LE, Mikkelsen T, Jain R, Paleologos NA, Rn PL, Prados M, Goldin J, Wen PY, Cloughesy T (2012) Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study. J Neurooncol 108:491\u2013498. doi: 10.1007\/s11060-012-0847-y","journal-title":"J Neurooncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1490-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-014-1490-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-014-1490-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T03:49:56Z","timestamp":1565495396000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-014-1490-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,30]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["1490"],"URL":"https:\/\/doi.org\/10.1007\/s11060-014-1490-6","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,30]]}}}